did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

did-you-know? rent-now

Amazon no longer offers textbook rentals. We do!

We're the #1 textbook rental company. Let us show you why.

9780521874908

Pharmaceutical Innovation: Incentives, Competition, and Cost-Benefit Analysis in International Perspective

by
  • ISBN13:

    9780521874908

  • ISBN10:

    0521874904

  • Edition: 1st
  • Format: Hardcover
  • Copyright: 2007-04-30
  • Publisher: Cambridge University Press

Note: Supplemental materials are not guaranteed with Rental or Used book purchases.

Purchase Benefits

List Price: $82.99 Save up to $27.80
  • Rent Book $55.19
    Add to Cart Free Shipping Icon Free Shipping

    TERM
    PRICE
    DUE
    SPECIAL ORDER: 1-2 WEEKS
    *This item is part of an exclusive publisher rental program and requires an additional convenience fee. This fee will be reflected in the shopping cart.

Supplemental Materials

What is included with this book?

Summary

The pharmaceutical industry worldwide is a rapidly burgeoning industry contributing to growth of gross domestic product and employment. Technological change in this field has been very rapid, with many new products being introduced. For this reason in part, health care budgets throughout the world have increased dramatically, eliciting growing pressures for cost containment. This book explores four important issues in pharmaceutical innovations: (1) the industry structure of pharmaceutical innovation; (2) incentives for correcting market failures in allocating resources for research and development; (3) competition and marketing; and (4) public evaluation of the benefits and costs of innovation. The lessons are applicable to countries all over the world, at all levels of economic development. By discussing existing evidence this book proposes incentive arrangements to accomplish social objectives.

Table of Contents

Introduction
The Industry Structure of Pharmaceutical Innovation
The pharmaceutical sector in health care
The economics of research and development in the pharmaceutical industry
Structuring Incentives for Research and Development
Drugs for neglected diseases: new incentives for innovation
When patents fail: finding new drugs for the developing world
Implementing a public subsidy for vaccines
Ensuring the future supply of vaccines: is a National Vaccine Authority the answer?
Competition and Marketing
Competition between generic and branded drugs
The United States' experience with direct-to-consumer advertising of prescription drugs: what have we learned?
Public Evaluation of the Benefits and Costs of Innovation
Measures of costs and benefits for drugs in cost effectiveness analysis
Using economic evaluation in reimbursement decisions for health technologies: lessons from international experience
Pharmaceutical spending and health outcomes
Pharmaceutical innovation and health outcomes: empirical evidence from
Conclusions and policy implications
Table of Contents provided by Publisher. All Rights Reserved.

Supplemental Materials

What is included with this book?

The New copy of this book will include any supplemental materials advertised. Please check the title of the book to determine if it should include any access cards, study guides, lab manuals, CDs, etc.

The Used, Rental and eBook copies of this book are not guaranteed to include any supplemental materials. Typically, only the book itself is included. This is true even if the title states it includes any access cards, study guides, lab manuals, CDs, etc.

Rewards Program